Chr. Hansen Holding — Director's Dealing 2015

Dec 4, 2015

CHR HANSEN
Improving food & health
COMPANY ANNOUNCEMENT
NO.26/2015
4 December 2015

Reporting of transactions in shares and associated securities of Chr. Hansen Holding A/S by senior employees

Pursuant to section 28a of the Securities Trading Act, Chr. Hansen Holding A/S is required to disclose information on transactions with the shares and associated securities of Chr. Hansen Holding A/S by senior employees and their associated persons or companies.

Chr. Hansen Holding A/S has received information on below transactions:

Name of the reporting person	Knud Vindfeldt
Reason for the reporting	Executive Vice President
Name of the issuer	Chr. Hansen Holding A/S
Securities code	DK 0060227585
Nature of the transaction	Exercise of stock options in Chr. Hansen Holding A/S
Type of security	Stock options
Trading date	3 December 2015
Trading market	Nasdaq Copenhagen
Number of securities	105,660
Market value on the trading date	DKK 44,704,746.00

Reporting of transactions in shares and associated securities of Chr. Hansen Holding A/S by senior employees
Chr. Hansen Holding A/S
Beoge Allé 10-12
DK-2970, Hoersholm
Denmark
Tel. +45 45 74 74 74
www.chr-hansen.com
CVR-no: 28318677

---

Name of the reporting person	Knud Vindfeldt
Reason for the reporting	Executive Vice President
Name of the issuer	Chr. Hansen Holding A/S
Securities code	DK 0060227585
Nature of the transaction	Sale of shares in Chr. Hansen Holding A/S
Type of security	Shares
Trading date	3 December 2015
Trading market	Nasdaq Copenhagen
Number of securities	44,095
Market value on the trading date	DKK 19,000,364.73

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618

Klara Halkjaer, Head of Media Relations
Tel: +45 4574 7474

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2014/15 financial year was EUR 859 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.

Reporting of transactions in shares and associated securities of Chr. Hansen Holding A/S by senior employees

Chr. Hansen Holding A/S
Tel. +45 45 74 74 74
Boege Allé 10-12
www.chr-hansen.com
DK-2970, Hoersholm
CVR-no: 28318677
Denmark